Dysphagia Knowledge Hub — 吞嚥困難知識庫

Huntington’s Disease and Dysphagia: Caring for Chorea-Affected Eating in Hong Kong

Huntington’s disease (HD) is an autosomal dominant neurodegenerative condition caused by a CAG repeat expansion in the HTT gene on chromosome 4. It affects approximately 5–10 per 100,000 people in Western populations; precise prevalence data for Hong Kong are limited, but the condition is seen at the HA Neurology rare disease clinics. HD causes a triad of motor dysfunction (including chorea), cognitive decline, and psychiatric symptoms, all of which interact to make mealtime management uniquely challenging.

Dysphagia occurs in virtually all people with HD as the disease progresses, and is a leading cause of aspiration pneumonia — one of the most common causes of death in advanced HD. Unlike many other neurological conditions, HD dysphagia is shaped not only by weakness and incoordination but by the involuntary choreic movements that characterise the disease and by the cognitive and behavioural changes that affect safe mealtime behaviour.


How Chorea Affects Swallowing

Chorea — the hallmark involuntary movement of HD — consists of brief, irregular, unpredictable muscle contractions that move from one body part to another. In swallowing, chorea affects every phase:

Oral Phase

Pharyngeal Phase

Respiratory Coordination


Managing Impulsive Eating Behaviour

Cognitive and psychiatric changes in HD frequently include impulsivity, reduced awareness of risk, and difficulty regulating eating behaviour. These features create specific mealtime safety problems that are not shared by most other neurological dysphagia populations:

Rapid eating (overstuffing): Patients may place large amounts of food in the mouth before swallowing the previous bolus. This creates an unmanageable bolus volume and significantly increases aspiration risk.

Strategies:

Grabbing food unexpectedly: Involuntary chorea combined with impulsivity may cause the patient to reach for food on another person’s plate, attempt to eat food that is not yet prepared to a safe texture, or grab the serving dish. Caregivers need to:


Caregiver Safety During Mealtimes

Mealtimes with HD patients present physical safety risks to caregivers that are uncommon in other dysphagia contexts:

Caregiver fatigue: Mealtimes in advanced HD can take 45–60 minutes and require constant vigilance. Split mealtimes across two caregivers if available, particularly for dinner. Caregiver support through the social work team at the treating neurology clinic is important — burnout in HD caregivers is significant.


Diet Texture Progression Across HD Stages

HD is classified into five stages by the Total Functional Capacity (TFC) scale (Shoulson, 1979), with Stage 1 (independent) to Stage 5 (requiring full assistance). IDDSI texture progression broadly follows this:

Stage 1–2 (TFC 11–13, mild): Most patients eat normally or nearly normally. Dysphagia is subclinical. Focus on:

Stage 2–3 (TFC 7–10, moderate): Choreic swallowing begins to affect mealtime safety. Transition toward IDDSI Level 6 (Soft and Bite-Sized) for solids — avoiding all hard, crunchy, or difficult-to-chew components. Liquids: assess with syringe flow test; many patients require Level 1–2 at this stage.

Stage 3–4 (TFC 3–6, moderately advanced): Chorea is more prominent, impulsivity more severe, and cognitive decline limits the patient’s ability to follow mealtime instructions. IDDSI Level 5 (Minced and Moist) or Level 4 (Pureed) typically required. Liquids: Level 2–3 thickening common. Caregiver-assisted feeding transitions from support to full assistance. The Huntington’s Disease Society of America guidelines (used internationally including in HK practice) recommend early SLP review at this stage and proactive PEG discussion.

Stage 5 (TFC 0–2, advanced): Full caregiver dependence. IDDSI Level 4 (Pureed) or Level 3 (Liquidised) for most patients. Full thickening of liquids (Level 3–4). Spoon-feeding by caregiver required for all meals. PEG decision typically active.


PEG Decision Ethics in HD: A Complex Conversation

The decision about percutaneous endoscopic gastrostomy (PEG) tube insertion in HD is ethically more complex than in most other neurological conditions, for several reasons:

Cognitive decline and autonomous decision-making: HD causes progressive cognitive decline that reduces the patient’s capacity to make informed decisions. The window for a competent advance decision about PEG is often earlier in the disease than expected — this conversation should occur at Stage 1–2, not Stage 4–5.

Quality of life considerations: For many HD patients and families, oral eating — even if unsafe — is an important component of quality of life and social participation. PEG feeding removes this. At the same time, aspiration pneumonia in late HD causes significant suffering. There is no universally correct answer.

Disease trajectory: Unlike ALS, where PEG can maintain meaningful life quality for extended periods, advanced HD involves severe motor, cognitive, and psychiatric disability. The marginal benefit of PEG in extending life must be weighed against the quality of that extended period.

HD-specific guidance: The Huntington’s Disease Foundation and HDSA guidelines recommend that PEG discussion should be initiated no later than Stage 3, preferably Stage 2, when the patient has capacity to contribute to the decision. Document the discussion and the patient’s preferences in an advance directive.

In Hong Kong: Advance directives (預設醫療指示) are legally valid under the Mental Health Ordinance. HD patients with capacity should be encouraged to complete one early in the disease, specifying their wishes regarding artificial nutrition, resuscitation, and level of intervention at end of life. The social work team and clinical ethics consultation service at the treating hospital can facilitate this process.


HK Neurology for Rare Diseases

HD is classified as a rare disease in Hong Kong. Management is concentrated in specialist rare neurological disease clinics:

Queen Mary Hospital (QMH), Neurology Department: The primary centre for complex and rare neurological conditions in the HA West Cluster. Movement disorder specialists with experience in HD. Multidisciplinary team including SLP, dietetics, physiotherapy, occupational therapy, and social work.

Prince of Wales Hospital (PWH), Neurology: CUHK-affiliated rare disease expertise. Movement disorder clinic with HD management capacity.

Genetic counselling: HD is hereditary with 50% transmission probability to first-degree relatives. Genetic counselling is available through the Clinical Genetics Service at QMH for at-risk family members considering predictive testing.

Referral pathway: GP or specialist → SOPC neurology → movement disorder clinic → multidisciplinary HD team. Due to rarity, patients may experience longer waiting times for specialist review. The social work team can assist with expediting when clinical urgency is established.


Advance Care Planning for HD Families

Because HD is hereditary and affects multiple family members across generations, advance care planning in HD has implications beyond the individual patient:

The Hong Kong Neurological Society and HA rare disease team can connect families with international HD support networks. In the absence of a dedicated HK Huntington’s Disease Society, the UK HD Association and HDSA (USA) provide English-language resources widely used by clinicians and families in Hong Kong.


Summary

Huntington’s disease creates a distinctive dysphagia profile shaped by choreic oral and pharyngeal movements, impulsive eating behaviour, and progressive cognitive decline. Key management principles: